Code No. SIN-201 2,500U
This product is a recombinant type human ribonuclease inhibitor purified using a combination of ion exchange and affinity chromatography.
This inhibitor exhibits broad-spectrum RNase inhibitory properties, including RNase A, RNase B, RNase C and human placental RNase. Does not inhibit RNase T1, S1 nuclease, RNase from Aspergillus, and RNase H. The 50kDa protein exerts its inhibitory effect by noncovalently binding to RNases in a 1:1 ratio. This inhibitor can be applied to a reverse transcriptase reaction.
E. coli strain carrying the cloned human placenta ribonuclease inhibitor gene
One unit is defined as the amount of RNase inhibitor required to inhibit the activity of 5 ng of ribonuclease A by 50%.
20 mM Hepes-KOH (pH 7.6), 50 mM KCl, 8 mM DTT, 50% Glycerol
Store at -20ºC
RNase inhibitor (20-40 U/µL)*
* Specific activity : approximately 100 U/µg protein
Reverse transcription was performed with a random primer using total RNA from HeLa cells as a template with or without RNase inhibitor and RNase A. The results of amplification of human IL-8 genes from the cDNA suggest that the addition of RNase inhibitor to the reverse transcription step effectively and efficiently protects mRNA.